Clinical Trials
9 trialsNCT03829020 2024-08-22
Metformin, Nelfinavir, and Bortezomib in Treating Patients With Relapsed and/or Refractory Multiple Myeloma
Mayo Clinic
Phase 1 Completed
NCT01068327 2023-10-10
Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer
University of Nebraska
Phase 1 Completed
NCT02363829 2020-04-06
A Study of Nelfinavir Added to Cisplatin Chemotherapy Concurrent With Pelvic Radiation for Locally Advanced Cervical Cancer (II-IVA)
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01445106 2019-12-17
A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01164709 2019-05-15
Nelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic Cancer
Swiss Cancer Institute
Phase 1 Completed
NCT01020292 2019-04-12
A Trial of the Protease Inhibitor Nelfinavir and Concurrent Radiation and Temozolomide in Patients With WHO Grade IV Glioma
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT01485731 2015-06-03
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
University of Miami
Phase 1 Completed
NCT00694837 2015-04-10
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
Maastricht Radiation Oncology
Phase 1 Completed
NCT01079286 2013-07-15
I-NET
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1 Completed